US$ 26.01
glp-1/gip injections Microdosed Tirzepatide Personalized GLP-1/GIP+B12 - Kin Meds
Description
Plaintiffs allege the drug has been linked to severe gastrointestinal injuries, including gastroparesis, as well as vision loss and other complications that have disrupted patients health, nutrition, employment, and daily functioning

DKA can sometimes happen even when blood glucose levels are not extremely high

Are the medications FDA-approved

Tirzepatide (Mounjaro, Zepbound, compounded) Tirzepatide acts on both GIP and GLP-1 receptors, creating a dual mechanism that produces greater weight loss but also a distinct side effect profile

The medications are prescribed for diabetes and weight loss

Herbal Supplements: Certain herbs, like berberine and cinnamon, may help with blood sugar control
